DiaMedica Therapeutics Inc.
DMAC
$6.59
$0.050.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.91% | -30.00% | -34.05% | -47.09% | -48.63% |
| Total Depreciation and Amortization | 48.57% | 2.38% | 10.26% | 19.44% | 2.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 94.58% | 138.07% | 265.48% | 256.50% | 288.79% |
| Change in Net Operating Assets | 20.56% | -66.38% | -55.36% | 17.85% | 701.67% |
| Cash from Operations | -22.85% | -37.32% | -31.65% | -42.55% | -29.67% |
| Capital Expenditure | 2.94% | -28.57% | -60.00% | -95.24% | -54.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -176.21% | -198.96% | -125.06% | -151.99% | -6.47% |
| Cash from Investing | -176.60% | -199.54% | -125.60% | -152.54% | -6.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 9.09% | -11.11% | -57.14% | -83.33% |
| Issuance of Common Stock | 8,711.07% | 268.79% | 268.96% | 172.49% | -95.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8,823.84% | 265.73% | 265.82% | 168.72% | -95.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.24% | 363.21% | 931.49% | -142.48% | -221.03% |